ZBiotics
ZBiotics, headquartered in San Francisco, is a biotech company that launched the world's first genetically engineered probiotic to break down acetaldehyde, a toxic byproduct of alcohol, and is developing a range of probiotics for consumer health applications.
Company Overview
Founded in 2016, ZBiotics is headquartered in San Francisco, California. This company operates within the healthcare industry, specifically focusing on consumer health and wellness. ZBiotics has a team of 22 employees and participated in the Y Combinator W18 batch.
Innovative Products
ZBiotics has launched the world’s first genetically engineered probiotic, designed to break down acetaldehyde, a toxic byproduct of alcohol. Branded as ZBiotics® Pre-Alcohol Probiotic, this product is aimed at improving consumer health related to alcohol consumption. Additionally, ZBiotics is developing a pipeline of engineered probiotics for other consumer health applications.
Availability and Customer Support
ZBiotics' products are available for purchase directly through their website, which also features a comprehensive FAQ section for customer support. The company offers free delivery on every purchase and bulk pack options. The website also includes customer reviews and testimonials, providing a platform for user feedback.
Scientific Approach
ZBiotics engages in synthetic biology to innovate and create their probiotic products. They promote the science behind their offerings through a dedicated section on their website. The company aims to apply genetic engineering transparently and responsibly to improve people's lives, reflecting their mission-driven approach.
Geographical Reach
ZBiotics operates primarily in the United States, with availability extending to America and Canada. They offer both remote and partly remote engagement options, catering to a broader audience.